Загрузка...
Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence
The introduction of liver transplant listing criteria for hepatocellular cancer (HCC) has significantly improved oncological outcomes and survival. But despite this HCC recurrence is still problematic. There is emerging evidence that the choice of immunosuppression (IS) after transplant for HCC can...
Сохранить в:
| Опубликовано в: : | Transl Gastroenterol Hepatol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5244705/ https://ncbi.nlm.nih.gov/pubmed/28138592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2016.03.18 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|